甘草查尔酮A (Licochalcone A, Lico A)是甘草中提取出的天然活性化合物,因具备强大的药理学作用而引起众多国内外研究者的关注,并被广泛用于治疗炎症相关性疾病。此外,还可以作为抗菌剂应用于医学领域。我们综述了现有研究成果及最新...甘草查尔酮A (Licochalcone A, Lico A)是甘草中提取出的天然活性化合物,因具备强大的药理学作用而引起众多国内外研究者的关注,并被广泛用于治疗炎症相关性疾病。此外,还可以作为抗菌剂应用于医学领域。我们综述了现有研究成果及最新研究进展,总结了甘草查尔酮A在治疗领域的应用及其相关的分子机制,旨在为研究者们更深入地研究甘草查尔酮A提供参考。Licochalcone A (Lico A) is a naturally occurring active compound derived from licorice, which has garnered significant attention from researchers both domestically and internationally due to its potent pharmacological effects. It has been extensively utilized in the treatment of inflammation-related diseases, and also exhibits antibacterial properties in the medical field. In this review, we have examined existing research findings and recent advancements, summarized the application of Licochalcone A in therapeutic settings along with its associated molecular mechanisms. The aim is to provide researchers with a reference for further investigation into Licochalcone A.展开更多
近年来癌症基因组图谱(The Cancer Genome Atlas,TCGA)和国际癌症基因组联盟(International Cancer Genome Consortium,ICGC)等大规模肿瘤基因组计划的实施,以及伴随的基因组、转录组、蛋白质组和生物信息学等组学技术的快速发展,极大...近年来癌症基因组图谱(The Cancer Genome Atlas,TCGA)和国际癌症基因组联盟(International Cancer Genome Consortium,ICGC)等大规模肿瘤基因组计划的实施,以及伴随的基因组、转录组、蛋白质组和生物信息学等组学技术的快速发展,极大推动了肿瘤突变谱鉴定及其产生的肿瘤新抗原(neoantigen)的研究。本文就肿瘤新抗原的鉴定以及基于肿瘤新抗原的免疫治疗技术包括肿瘤治疗性疫苗和细胞治疗等技术的研发作一综述。展开更多
文摘甘草查尔酮A (Licochalcone A, Lico A)是甘草中提取出的天然活性化合物,因具备强大的药理学作用而引起众多国内外研究者的关注,并被广泛用于治疗炎症相关性疾病。此外,还可以作为抗菌剂应用于医学领域。我们综述了现有研究成果及最新研究进展,总结了甘草查尔酮A在治疗领域的应用及其相关的分子机制,旨在为研究者们更深入地研究甘草查尔酮A提供参考。Licochalcone A (Lico A) is a naturally occurring active compound derived from licorice, which has garnered significant attention from researchers both domestically and internationally due to its potent pharmacological effects. It has been extensively utilized in the treatment of inflammation-related diseases, and also exhibits antibacterial properties in the medical field. In this review, we have examined existing research findings and recent advancements, summarized the application of Licochalcone A in therapeutic settings along with its associated molecular mechanisms. The aim is to provide researchers with a reference for further investigation into Licochalcone A.
文摘近年来癌症基因组图谱(The Cancer Genome Atlas,TCGA)和国际癌症基因组联盟(International Cancer Genome Consortium,ICGC)等大规模肿瘤基因组计划的实施,以及伴随的基因组、转录组、蛋白质组和生物信息学等组学技术的快速发展,极大推动了肿瘤突变谱鉴定及其产生的肿瘤新抗原(neoantigen)的研究。本文就肿瘤新抗原的鉴定以及基于肿瘤新抗原的免疫治疗技术包括肿瘤治疗性疫苗和细胞治疗等技术的研发作一综述。